Growth Financing for 1Q Health Group

Cadenive acted as sole debt advisor to 1Q Health GmbH, a portfolio company of NORD Holding, in the structuring and negotiation of growth financing for further buy-and-build activities. The financing structure builds on NORD Holding’s buy-and-build strategy and creates a resilient financing basis for further organic and inorganic growth of the 1Q Health Group. The transaction also financed the acquisition of the Dutch EHF Group, accelerating the group’s international expansion. The financing underlines the lenders’ confidence in 1Q Health’s strategy and its positioning as a European CDMO platform for dietary supplements and pharmaceuticals. 1Q Health Group is a European CDMO platform for dietary supplements and pharmaceuticals. The group employs around 420 people and produces hard capsules, liquids, powders and tablets under GMP and IFS/FSSC conditions at five production sites in Germany, Austria and the Netherlands. As a one-stop shop provider, 1Q Health supports customers across the product lifecycle, from development and production to logistics and regulatory support.

For further information please contact info@ncf.de (+49 (0)211 / 239 417 0).